Scientific Advisory Board
- Ola Engkvist, Astra-Zeneca, Sweden (Image based drug screening and commercialization)
- Peter Friedl, Raboud University, Nijmegen, The Netherlands/MD Anderson, Houston, USA (Cell migration and advanced microscopy)
- Wolfgang Huber, EMBL, Heidelberg, Germany (Statistics, Bioinformatics and Modeling)
- Xiaowei Zhuang, Harvard University, Boston, USA (Quantitative and highly multiplex imaging)
Updated by:
Gabriela Imreh 2020-07-08